The results showed CRSP8 re-expression restored the decreased cell growth and invasive ability to almost baseline levels in ATC cells (Supplementary Fig. S4B, C), suggesting CRSP8 indeed drives thyroid cancer cell survival. Here, MED27 is linked to thyroid gland carcinoma.